藥業奇才李楚源捧紅「板藍根」、「國產偉哥」和「王老吉」三大產品,卻難逃被整肅命運|【 #人物真相】

人物真相
1109粉絲
#李楚源 #廣藥集團 #板藍根 #金戈 #王老吉 #人物真相
00:00 李楚源——板藍根的重要推手任上落馬
01:40 板藍根讓其一戰成名
04:32 首推國產偉哥 獲取暴利
06:29 利用百年老字號發大財
11:07 醫藥行業遭清洗 李楚源難逃此劫
引言:廣州醫藥集團董事長李楚源在任上落馬,他在位期間,見證與推動了板藍根、國產偉哥、王老吉這三大著名產品的興起。
發表時間:2024年 8月20日
責任編輯:Jinbo
Li Chu-yuan, the CEO of Guangzhou Medical Group,
for creating a national crisis or violence
in the medical industry.
At this time, his project is under construction
and he will retire on the spot,
with only one year left.
As a brilliant businessman,
Li Chu-yuan witnessed and promoted
the rise of three famous products,
and has dominated the Chinese medicine industry
for more than 20 years.
Li Chu-yuan was born in 1965
in Shantou, Guangdong.
In 1984, he was admitted to
the Department of Chemistry of Zhongshan University.
After graduating from this department,
he joined the pharmaceutical company
Baiyunshan in Guangzhou.
From an ordinary technician,
he was appointed as chief of department,
minister, assistant general manager,
deputy general manager, general manager, and so on.
In 1999, Li Chu-yuan was appointed
as the director of Baiyunshan Chinese Medicine Factory.
It took him nearly 10 years
to turn the factory into a well-known
pharmaceutical pioneer in China.
In 2013, Li Chu-yuan was appointed
as the chief executive of
Baiyunshan's parent company,
Guangzhou Medical Group.
He is indeed very business-minded.
Eight years later,
Guangyao Group has become
the world's first 500-strong
pharmaceutical company.
For more than 20 years,
Li Chu-yuan has won numerous awards.
He is the model of labor in Guangdong,
the innovator of 10 major Asian brands,
the man of the year of 10 major economies,
and the chief executive
of 10 major Chinese brands.
However, he is the one
who has made a great contribution
to the CCP,
but now he is in prison.
In the 1990s,
Baiyunshan Chinese Medicine Factory
was in a huge challenge.
It suffered losses for 15 years in a row,
including a loss of 8.19 billion yuan
which was about 100 million US dollars.
Under the crisis,
Baiyunshan began to reform.
At that time,
who was the assistant of the chief executive,
was killed.
In 1999,
he took over the position
Baiyunshan Chinese Medicine Factory
under Baiyunshan.
In 2000,
the epidemic of cold
swept Europe,
and the effect of chemical drugs
was not good.
The WHO was looking for good medicine,
and a batch of Chinese medicine
was also included in the observation range.
As a Chinese,
Baiyunshan Chinese Medicine Factory
is one of the core products
which is widely used
and recommended by the WHO.
This is a great opportunity
With the endorsement of the WHO,
Li Chuyuan quickly pushed
Banlangen overseas.
In his first year in office,
Baiyunshan Chinese Medicine Factory
made more than 16 million yuan.
Next, Li Chuyuan took another opportunity.
The regulatory policy of the CDC
required to stop the use
of all cold medicine containing PPA.
At that time,
many kinds of cold medicine in China,
including the well-known brand Contact,
all contained PPA.
Li Chuyuan was famous
for the cold medicine
containing PPA
when he marketed Banlangen.
This made the Chinese public
remember the name Baiyunshan more.
In 2002,
Li Chuyuan led Baiyunshan
to build China's largest
Banlangen GAP base.
He may have never dreamed
of the so-called non-typical pneumonia
caused by severe acute respiratory syndrome
in China the next year.
Banlangen has no prevention
and treatment effect
and no medical evidence.
But under the recommendation
of the Chinese authorities
and experts,
the media propaganda,
people's trust in traditional Chinese medicine
and the fear of unknown infectious diseases,
Banlangen became famous
all over the world.
In 2003,
Baiyunshan Chinese Medicine Factory
surged to 4.7 billion yuan
with a profit of more than 50 million yuan.
In 1998,
Baiyunshan Chinese Medicine Factory
was only 7.8 million yuan.
With the success of Banlangen,
Li Chuyuan became famous.
Under his subsequent series of operations,
Banlangen was almost given
the glory of all-purpose medicine.
In the later 20 years,
it has not declined for a long time.
Whether it is the flu,
the flu,
or the recent Covid-19 epidemic,
every special period,
Banlangen will attract
the public's attention
and make Baiyunshan
very popular.
In addition to the popularity of Banlangen,
Li Chuyuan also successfully launched
another heavyweight product,
which is the domestically produced
pseudo-medicine, Jinge.
The pseudo-medicine produced by
the U.S. Pfizer pharmaceutical company
has been on the market since 1998
and has brought benefits
to tens of thousands of men
with sexual dysfunction.
Li Chuyuan sees it in his eyes
and remembers it in his heart.
In 2012, the Guangzhou Medical Group
established the Guangzhou Medical Research Institute
and was willing to hire
the Nobel Prize winner
Friedrich Murad as the president.
Murad was nicknamed
the father of the pseudo-medicine
Perhaps Murad's high salary
has caused a lot of criticism.
But Li Chuyuan actually said,
what I want is the resources
that Nobel Prize winner Murad
has mastered in the world.
His resources are more valuable
than his own experiments in the laboratory.
On the surface,
I did a bad deal.
But in fact,
the value behind this deal
is bigger than we think.
In 2014,
China's first pseudo-medicine Jinge was approved.
As expected by Li Chuyuan,
Jinge's sales have skyrocketed
In 2014, Jinge sold
292 million copies.
In 2018, Jinge increased
to 47.74 million copies.
In 2023,
Jinge sold 1.01 billion copies
and brought 12.9 billion yuan
to Baiyunshan.
The gross profit was 91.76%.
Jinge was the first company
to generate more than
10 billion yuan.
Jinge became Baiyunshan's
cash cow.
There are many Chinese pharmaceutical companies
that value pseudo-medicine.
It is said that more than 20 companies
applied for production approval
at that time.
Guangyao applied for the first batch
and took the lead.
Liangcha brand Wanglaoji
is another treasure of Guangyao Group.
A study in 2010 showed
that Wanglaoji is the first brand
to generate more than
1.08 billion yuan.
At that time,
Wanglaoji's sales volume
in China was more than Coca-Cola.
Wanglaoji was founded
by Wang Zebang,
Wanglaoji became
an old company
because of its age.
Wanglaoji has devoted his life
to medicine.
Wanglaoji's Liangcha formula
can help villagers
to avoid disasters.
Therefore,
Wanglaoji was appointed
by Emperor Daoguang
as the head of the Imperial Hospital.
People call him Liangcha King.
After the CCP took power,
all national brands
were taken over by the CCP
through so-called joint venture.
Wanglaoji is no exception.
In 1983,
the CCP began to implement the trademark law.
In the early days of Guangyao Group,
the Yangcheng Pharmaceutical Factory
in Guangzhou re-registered
the trademark of Wanglaoji.
In 1992,
Guangyao Group launched
Hezhuang Wanglaoji
and Guanzhuang Wanglaoji Liangcha.
However,
a descendant of Wang's family
opened Wanglaoji Liangcha
in Hong Kong and Macao
In 1990,
Chen Hongdao,
the founder of Jaduobao Group,
reached a cooperation agreement
the descendant of Wang.
The Hong Kong Wanglaoji Limited Company
authorized Jaduobao Group
to use Wang's formula
and trademark to produce beverages.
Wang Jianyi later insisted
to pass the ancestral formula
exclusively to Jaduobao Group.
Since the Liangcha produced by Jaduobao
cannot be named
with Wang's name in China,
Chen Hongdao found
Guangyao Group in 1994
and asked for permission
to use the trademark of Wanglaoji.
The two sides
reached an agreement
and signed the contract.
However,
the contract broke
after more than ten years.
The huge interest
led to the long-term Liangcha dispute.
Jaduobao and Guangyao
used the trademark,
commercial terms,
packaging of Wanglaoji,
and formula of Wanglaoji.
This century-long lawsuit
continued to escalate
from 2010 to now.
Guangyao Group is
a Chinese state-owned
investment company
Private enterprises
rarely have a chance
to use the trademark of Wanglaoji.
Jaduobao lost.
This means
Wanglaoji's production
is monopolized by Guangyao Group.
Li Chuyan immediately began
the so-called
big health industry
In the following years,
more than 60 products
about Wanglaoji
such as milk,
wine,
vegetable drinks,
ice cream,
toothpaste,
face wash,
etc.,
were launched.
In order to fully
use the brand value of
Li Chuyan came up with
an idea to
open a trademark authorization
for Wanglaoji.
In 2019,
Guangyao Group established
a Guangzhou startup company
specializing in the
brand authorization business of
Guangyao Group.
As of today,
Guangzhou startup company
shows that
more than 350 products
including Wanglaoji,
Baiyunshan,
etc.,
have been launched.
It is said that
every time a company
signs a brand authorization contract,
Guangyao Group can
earn 5 million yuan a year.
According to the financial annual report,
Wanglaoji's big health company
achieved a revenue of
100.12 billion yuan in 2023
and a net profit of 12.6 billion yuan.
These frequent brand authorizations
actually buried a lot of traps
for Wanglaoji and Guangyao Group.
Because the authorized company
can also be authorized
to other companies.
Therefore, there are a lot of
related product agents
who claim to be Wanglaoji brands
all over China.
Many people think
this is not good for Wanglaoji's brand.
But Li Chuyuan doesn't care so much.
Anyway, the brand is welcome.
The lawsuit is still controversial.
Let's earn the money first.
Banlanggen, Jingge, Wanglaoji,
these three big money-making products
were all created when Li Chuyuan was in office.
Its process also basically corresponds
to Li Chuyuan's career.
On the evening of July 22,
Baiyunshan issued a notice.
For personal reasons,
Li Chuyuan resigned from the company,
the chairman and other positions,
and no longer served any positions in the company.
But multiple sources confirmed
that Li Chuyuan had been taken by relevant departments
to investigate.
It is said that his family members
Li Chuyuan often caused controversy
because of some unfavorable remarks.
A few years ago,
he was accused of illegal business.
But these may not be the real reason
Since last year,
the CCP's anti-corruption storm has been
sweeping the Chinese medical industry
with high pressure.
In May this year,
the well-known medical enterprise
Yunnan Baiyao broke out.
Former chairman Wang Minghui
and other senior executives
were taken by relevant departments
to investigate.
In August last year,
Liu Jianshun,
the secretary of the original unit
of Laozihao Pianzaihuang,
was investigated
and expelled from the party.
At least five senior executives
were investigated
and many senior executives
resigned.
In February last year,
Chairman Gao Dengfeng
and Vice President Zhang Mingjun
both resigned.
Former Party Secretary of East Russia,
Vice President Qin Yufeng
and Senior Vice President Wu Huifeng
have been investigated and investigated.
Although Li Chuyuan has some experience
it is hard to say
whether he will be in the hands
of the CCP's own people in the future.
Li Chuyuan joined the party in 1991
and was the party secretary
of the Communist Party of China.
He should know that
very few people can escape
from the CCP.
In this case,
he will not only have nothing
but also be in jail.
